103 [89Zr]Zr-DFO-durvalumab PET/CT before durvalumab treatment in R/M SCCHN patients A B Figure S2. Kaplan-Meier estimates of the overall survival and progression free survival The overall survival (A) and progression free survival (B) are displayed for all 31 patients treated with durvalumab. 5
RkJQdWJsaXNoZXIy MTk4NDMw